India faces a significant health and economic challenge due to rising obesity. The TBI report highlights the need for ...

With multiple drugs in late-stage clinical trials, several are expected to reach regulatory approval between late 2025 and ...

For decades, scientists have known that what harms the body often harms the brain. Conditions such as obesity, high blood ...

Although overweight, obesity and high-intensity statin therapy can increase diabetes risk, new evidence demonstrates cardiorespiratory fitness has a protective effect.

Discover why Rhythm Pharmaceuticals, Inc. earns a strong buy as IMCIVREE expands in rare obesity markets. Click for this ...

Analysis of 135,000 participants reveals 11 genetic regions tied to delayed gratification and shows shared biology with ...

Obesity is one of the most common and complex chronic diseases clinicians encounter in practice. Yet it is still often ...

Increasingly, telehealth platforms are positioning blockbuster weight-loss shots not as medicines to treat obesity or diabetes but as cosmetic elixirs for anyone who wants to lose a few pounds.

New research shows that young adults with obesity already display biological patterns associated with liver stress, chronic inflammation, and early neural injury—changes typically seen in older adults ...

Background: In January, Greystar was named as a defendant in an antitrust lawsuit filed by California Attorney General Rob ...

A Penn case study finds that a brain-computer interface shows the medication produces only short-term or incomplete effects on related brain activity in a patient with obesity, highlighting the need ...

Cornell University is enrolling client-owned cats in an 11-week trial of AKS-562c, a once-weekly GLP-1 Fc-fusion candidate designed to reduce appetite and produce clinically meaningful weight loss ...